Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cáncer
6
Agentes antineoplásicos
2
Aspectos moleculares
2
Diagnóstico
2
Histopatología
2
Carcinogénesis química
1
Citodiagnóstico
1
Enfermedades
1
Enfermedades de la próstata
1
Enfermería
1
Farmacología
1
Inmunodiagnóstico
1
Mamas
1
Merkel celulas
1
Merkel celulas carcinoma
1
Oncología
1
Patofisiología
1
Próstata
1
Quimioterapia
1
-
145801“…There were ten squamous, seven adeno and two large cell carcinomas. The median concentration of high affinity sites was 31 fmol per mg of protein (4-1532) and the median dissociation constant (Kd) of these high affinity sites was 2.3 x 10(-10) per mol (1.2-30 x 10(-10)). …”
Enlace del recurso
Enlace del recurso
Texto -
145802“…These results demonstrated the dominance of the p53 mutations with null protein expression in bone and soft tissue sarcomas, showing a unique characteristic of these types of tumours compared with other malignancies such as colon carcinomas. IMAGES:…”
Enlace del recurso
Enlace del recurso
Texto -
145803por Biesma, B., Willemse, P. H., Mulder, N. H., Verschueren, R. C., Kema, I. P., de Bruijn, H. W., Postmus, P. E., Sleijfer, D. T., de Vries, E. G.“…Malignant carcinoid tumours, islet cell tumours and medullary carcinomas of the thyroid are tumours with similar clinical features. …”
Publicado 1992
Enlace del recurso
Enlace del recurso
Texto -
145804“…There was an increased frequency of HLA-B5 in small-(oat-)cell anaplastic carcinomas (P less than 0.05); HLA-B15 in anaplastic tumours (P less than 0.05); HLA-B40 in Stage III patients (P = 0.05) and a decreased frequency of HLA-B12 in adenocarcinomas (P less than 0.05). …”
Enlace del recurso
Enlace del recurso
Texto -
145805“…The CEA doubling times concomitant with local recurrence or second primary carcinomas ranged from 142 to 868 days, visceral metastasis other than liver metastasis from 47 to 231 days and liver metastasis from 10 to 102 days. …”
Enlace del recurso
Enlace del recurso
Texto -
145806por Olive, P. L.“…The ability of the dual-function bioreductive drug, RSU 1069, to identify hypoxic cells in multicell spheroids and murine SCCVII squamous cell carcinomas was examined using the alkaline comet method. …”
Publicado 1995
Enlace del recurso
Enlace del recurso
Texto -
145807por Helle, S. I., Geisler, J., Poulsen, J. P., Hestdal, K., Meadows, K., Collins, W., Tveit, K. M., Holly, J. M., Lønning, P. E.“…Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment with microencapsulated octreotide pamoate 90 mg i.m. every 4 weeks (n = 4), 160 mg i.m. every 4 weeks (n = 4) or 160 mg i.m. every 2 weeks (n = 6). …”
Publicado 1998
Enlace del recurso
Enlace del recurso
Texto -
145808por Kubota, K., Yamada, S., Kondo, T., Yamada, K., Fukuda, H., Fujiwara, T., Ito, M., Ido, T.“…Increased FDG uptake was observed in nine of ten patients with malignant tumours, including thymic carcinomas, lymphomas, invasive thymomas and a case of sarcoidosis. …”
Publicado 1996
Enlace del recurso
Enlace del recurso
Texto -
145809por Wangberg, B., Forssell-Aronsson, E., Tisell, L. E., Nilsson, O., Fjalling, M., Ahlman, H.“…In patients with medullary thyroid carcinomas (eight out of ten scintigraphy positive), misleading Rin situ results were found in 4/37 macroscopically identified tumours. …”
Publicado 1996
Enlace del recurso
Enlace del recurso
Texto -
145810“…The von Hippel-Lindau tumor suppressor protein (pVHL) is inactivated in the hereditary cancer syndrome von Hippel-Lindau disease and in the majority of sporadic renal carcinomas. pVHL is the substrate-binding subunit of the CBC(VHL) ubiquitin ligase complex that negatively regulates cell growth by promoting the degradation of hypoxia-inducible transcription factor subunits (HIF1/2α). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145811por Kayagaki, Nobuhiko, Yamaguchi, Noriko, Nakayama, Masafumi, Eto, Hiroshi, Okumura, Ko, Yagita, Hideo“…Type I IFNs have been used for clinical treatment of renal cell carcinomas (RCCs), and we found that most RCC cell lines were susceptible to TRAIL-induced apoptosis. …”
Publicado 1999
Enlace del recurso
Enlace del recurso
Texto -
145812por Scambia, G., Masciullo, V., Benedetti Panici, P., Marone, M., Ferrandina, G., Todaro, N., Bellacosa, A., Jain, S. K., Neri, G., Piffanelli, A., Mancuso, S.“….; P = 0.014) and in omental metastases than in primary ovarian carcinomas (median 2.54 i.a. vs median 2.1 i.a.; P = 0.0089). p21 overexpression did not correlate with any of the clinicopathological parameters examined. …”
Publicado 1997
Enlace del recurso
Enlace del recurso
Texto -
145813“…We analysed p16 gene mutation and p16 protein expression in 42 primary ovarian carcinomas and in five human ovarian cancer cell lines. …”
Enlace del recurso
Enlace del recurso
Texto -
145814“…The nuclear DNA content of 351 breast carcinomas was determined by flow cytometry from paraffin-embedded tissue to assess the prognostic significance of DNA ploidy, the DNA index (DI) and the S-phase fraction (SPF). …”
Enlace del recurso
Enlace del recurso
Texto -
145815“…We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145816“…The purpose of this study was to compare the diagnostic interest of Hector Battifora mesothelial antigen-1 (HBME-1), thyroid peroxidase (TPO), and dipeptidyl aminopeptidase IV (DPP4) in thyroid fine-needle aspirates obtained from 200 resected thyroid lesions (55 colloid nodules, 54 follicular adenomas, 59 papillary cancers, and 32 follicular carcinomas). Hector Battifora mesothelial antigen-1 or TPO expression (% positive cells) and DPP4 staining score (12-point scale) were evaluated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145817por Kamangar, F, Qiao, Y-L, Blaser, M J, Sun, X-D, Katki, H, Fan, J-H, Perez-Perez, G I, Abnet, C C, Zhao, P, Mark, S D, Taylor, P R, Dawsey, S M“…In a cohort of 29 584 residents of Linxian, China, followed from 1985 to 2001, we conducted a case–cohort study of the magnitude of the association of Helicobacter pylori seropositivity with cancer risk in a random sample of 300 oesophageal squamous cell carcinomas, 600 gastric cardia adenocarcinomas, all 363 diagnosed gastric non-cardia adenocarcinomas, and a random sample of the entire cohort (N=1050). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145818por Kang, M K, Kim, R H, Kim, S J, Yip, F K, Shin, K-H, Dimri, G P, Christensen, R, Han, T, Park, N-H“…Bmi-1 protein and RNA expression levels were markedly enhanced in the cells of oral squamous cell carcinomas (OSCC) compared with that of normal human oral keratinocytes (NHOK). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145819Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational studypor Gunelli, R, Bercovich, E, Nanni, O, Ballardini, M, Frassineti, G L, Giovannini, N, Fiori, M, Pasquini, E, Ulivi, P, Pappagallo, G L, Silvestrini, R, Zoli, W“…Intravesical gemcitabine (Gem) has shown promising activity against transitional cell carcinomas (TCC) of the bladder, with moderate urinary toxicity and low systemic absorption. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
145820por Shimada, K, Uzawa, K, Kato, M, Endo, Y, Shiiba, M, Bukawa, H, Yokoe, H, Seki, N, Tanzawa, H“…This study was designed to identify specific gene expression changes in tongue squamous cell carcinomas (TSCCs) compared with normal tissues using in-house cDNA microarray that comprised of 2304 full-length cDNAs from a cDNA library prepared from normal oral tissues, primary oral cancers, and oral cancer cell lines. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto